Asthma is a chronic respiratory disease blocking the airways of the lungs because of the inflammation, mucus production, tighten of muscles. The general symptoms are coughing, wheezing, shortness of breath and/or chest tightness and majorly these symptoms are closely related to the physical activity. There are different types of asthma, exercise-induced bronchoconstriction(EIB), allergic asthma, occupational asthma, childhood asthma. Chronic Obstructive Pulmonary Disease (COPD) is also respiratory disease which causes obstructions and difficulty in breathing, the primary cause of COPD is tobacco smoking and chemical flumes, dust, air pollution are minor causes of the disease. Major symptoms are long lasting cough, mucus that comes out along with cough, shortness of breath.
The world COPD and asthma drugs market is expected to reach $50,359 million by 2022, growing at a CAGR of 3.7% from 2016 to 2022. Increase in prevalence of asthma and COPD, increase in world ageing population, technological advancement in the treatment of asthma and COPD, growth in initiatives implemented by the government and non-government associations for rise in health awareness play a pivotal role in the growth of the global COPD and asthma drug market. Stringent government regulatory requirement for the approval of COPD and asthma drug, patent expiry of branded hamper the market growth.
The world asthma and COPD drugs market is segmented based on disease and medication class and geography. On the basis of disease, the market is segmented into COPD and asthma. Based on medication class, the world asthma and COPD drug market is segmented into combination products, short acting beta agonists (SABA), long acting beta agonists (LABA), inhaled corticosteroids (ICS), leukotriene antagonists (LTA), anticholinergics and others. And geographically, the market is segmented into North America, Europe, Asia-Pacific, and LAMEA.
MARKET BY DISEASES
MARKET BY MEDICATION CLASS
MARKET BY GEOGRAPHY
Other players in the value chain include (profiles not included in the report)
SIMILAR MARKET STUDIES
Summary Lyka Labs Limited (Lyka Labs) is a pharmaceutical company that manufactures pharmaceutical formulations and active pharmaceutical ingredients. The company specializes in the development of various formulations including lyophilized injections, differentiated dermatological formulation, dry powder injections, topical stem cells products, cosmeceutical formulation, topical formulations of gels and lotions, foams, creams and ...
May 2016 | $250 | View Details >>
Summary Bio-Bridge Science, Inc. (Bio-Bridge) is a biotechnology company focused on the development and commercialization of biological products for the prevention and treatment of human infectious diseases. The company also undertakes the manufacture and sales of materials used in vaccine production such as bovine serum, which is a major production material ...
July 2014 | $250 | View Details >>
Generics BRIC (Brazil, Russia, India, China) Industry Guide-2017 Summary The BRIC Generics industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures ...
February 2017 | $995 | View Details >>
Summary Carena Inc. (Carena) is a telemedicine solution provider. The company serves patients via phone, Webcam, or house call to diagnose and treat injuries and illness. It offers virtual house call and in-home care services integrated with other company-sponsored health and productivity initiatives, including nurse lines, wellness programs, and care management, ...
May 2014 | $250 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research